Drug Development
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
cGMP Manufacture | Drug Development | Drug Discovery | Formulation Development | Industry News | Methods Development
Avista Pharma Details One-Stop-Shop Offerings
Analytical services director, Katie Schlipp, spoke with Contract Pharma at BIO 2018Videos
-
Bio News | cGMP Manufacture | Drug Development | Drug Discovery | Facilities | Industry News
-
Bioanalytical Services | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Information Technology
Comprehend Systems Joins Veeva Partner Program
To integrate solutions with Veeva Vault EDC & CTMS to provide pharma companies real-time performance & risk monitoring06.21.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Syneos, Elligo Enter Strategic Collaboration
To build a central infrastructure & research system around physicians & patients who aren't accessible in traditional sites06.21.18
-
Bio News | Collaborations & Alliances | Drug Development | Industry News
Pacira, Nuance Sign Agreement
For the development and commercialization of EXPAREL (bupivacaine liposome injectable suspension) in China06.19.18
-
cGMP Manufacture | Drug Development | Facilities | Fill/Finish | Formulation Development
Samsung BioLogics Details End-To-End Services
CDO Team Lead at Samsung BioLogics, Eun Young Yang, shares insight on the company’s one-stop CDMO offeringsVideos
-
Drug Development | Drug Discovery | Industry News | R&D
BridgeBio Launches CoA Therapeutics
To develop novel small-molecules designed to increase CoA levels in genetic disorders where CoA deficiency is implicated06.14.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Artelo, Syngene Enter Partnership
For the drug discovery and clinical development of ART27.13, Artelo's Phase 2 ready, high-potency dual cannabinoid agonist06.14.18
-
Drug Development | Drug Discovery | Facilities | Industry News
Eisai Launches Dementia Discovery Center
Over $100 million committed as an initial investment to establish the new 50,000 sq. ft. discovery center in Cambridge, MA06.14.18
-
Bio News | Biosimilars | Drug Development | Industry News
SGS Continues to Lead in Comparability Services
Business development manager Nicole Kovacs shares insight on SGS life sciences division's servicesVideos
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Alcami Extends Workbench Laboratory Services Program
To support the ongoing manufacturing and development of ZILRETTA for Flexion Therapeutics06.13.18
-
Drug Development
Journeying with CROs: Driving drug development efficiency
Multi-service CROs can deliver quality, efficiency, and cost reductions for drug developers.Lynn Lewis, Chief Commercial Officer, Envigo 06.12.18
-
Drug Delivery | Drug Development
Traveling Toward the Intersection of Drug Development and Delivery
Are We There Yet?Louise Righton, Global Marketing Operations Manager, 3M Drug Delivery Systems 06.12.18
-
Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Microbiotica, Genentech Announce Collaboration
To discover, develop and commercialize biomarkers, targets and medicines for inflammatory bowel disease06.12.18
-
Collaborations & Alliances | Drug Development | Industry News
BioMarin Receives Pfizer Milestone Payments
Totaling $20 million, the payments were triggered by the FDA's acceptance of Pfizer's NDA for talazoparib06.12.18
-
Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Alexion, Complement Enter Partnership
To co-develop the preclinical C6 complement inhibitor CP010 for neurodegenerative disorders06.12.18
-
CRO News | Drug Development | Laboratory Testing
LabCorp Acquires Sciformix Corp.
Expands pharmacovigilance capabilities for post-approval safety solutions06.11.18
-
Drug Development | Facilities
Patheon Talks Growing Business & Capacity Needs
Sr. Director of Scientific & Technical Affairs, David Kenyon, discusses the reasons for a second major capacity expansionVideos
-
Bio News | Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery
GE, XPH Enter FlexFactory Agreement
To scale up, digitize & accelerate manufacturing processes for their cell therapy clinical trials & future commercialization06.07.18
-
Bio News | Breaking News | Drug Development | Industry News
Biogen Acquires TMS' Phase 2 Asset for Acute Stroke
Biogen to pay $4 million upfront and $18 million upon exercise of the option, plus milestones of up to $335 million06.07.18
